Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
First Claim
Patent Images
1. A method for characterizing a cancer tumor for medical diagnosis and treatment, comprising:
- determining a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient'"'"'s tumor; and
selecting a cancer therapy regimen based on said cancer protein pattern for eradicating the tumor.
2 Assignments
0 Petitions
Accused Products
Abstract
A cancer therapy comprehensive method for characterizing a cancer tumor for medical diagnosis and treatment. The method facilitates determination of a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient'"'"'s tumor. A cancer therapy regimen is selected based on the cancer protein pattern for eradicating the tumor.
-
Citations
94 Claims
-
1. A method for characterizing a cancer tumor for medical diagnosis and treatment, comprising:
-
determining a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient'"'"'s tumor; and
selecting a cancer therapy regimen based on said cancer protein pattern for eradicating the tumor. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. A method for medical diagnosis and treatment of cancer, comprising:
-
obtaining an assay evaluation sample from a patient;
simultaneously testing said assay evaluation sample for upregulated or downregulated biomolecular markers (BMMs) representing a cancer protein pattern; and
selecting a cancer therapy regimen based on said cancer protein pattern. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A method for characterizing a cancer tumor for medical diagnosis and treatment, comprising:
-
obtaining an assay evaluation sample from a patient, said assay evaluation sample being either a homogenate of a solid tumor sample obtained from the patient or a blood serum/plasma sample obtained from the patient;
determining a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with the patient'"'"'s tumor;
selecting a cancer therapy regimen based on said cancer protein pattern for eradicating the tumor;
said cancer therapy regimen being a first line therapy regimen customized to target cells that express BMMs in said cancer protein pattern above or below basal levels;
said BMMs including proteins that can be modulated by protein modulating drugs and said cancer therapy regimen including protein modulating drugs corresponding to one or more of said BMMs;
said protein modulating drugs being selectively combined into a chemo-suite that directly corresponds to said BMM pattern;
said BMMs including Class I BMMs representing either tumor promoting or tumor suppressor proteins and Class II BMMs representing tumor marker proteins that provide information about cancer progression;
said cancer therapy regimen being selected by evaluating said Class I BMMs for upregulation or downregulation and evaluating said Class II BMMs if any of said Class I BMMs are upregulated or downregulated;
said cancer therapy regimen being selected by evaluating said Class I BMMs to determine if only one Class I BMM is upregulated or downregulated, and if so, designating the patient as being possibly precancerous;
said cancer therapy regimen being further selected by evaluating said Class I BMMs to determine if only two Class I BMMs are upregulated or downregulated, and if so, designating the patient as being precancerous; and
said cancer therapy regimen being further selected by evaluating said Class I BMMs to determine if three or more Class I BMMs are upregulated or downregulated, and if so, designating the patient as being cancerous.
-
-
21. A method for characterizing a cancer tumor for medical diagnosis and treatment, comprising:
-
determining a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient'"'"'s tumor;
selecting a cancer therapy regimen based on said cancer protein pattern for eradicating the tumor; and
said method being specific to one or more particular cancer types and implemented as either a basic profile comprising a first set of BMMs or a comprehensive profile comprising said first set of BMMs and a second set of BMMs. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)
-
-
58. A method for characterizing a cancer tumor for medical diagnosis and treatment, comprising:
-
determining a cancer protein pattern based on detected nonbasal levels of biomolecular markers (BMMs) associated with a patient'"'"'s tumor;
selecting a cancer therapy regimen based on said cancer protein pattern for eradicating the tumor; and
said method being implemented as a panel comprising a set of BMMs selected to provide cancer diagnostic information. - View Dependent Claims (59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94)
-
Specification